AparnaBio is a privately held, early stage biotech company located in
Rockville, Maryland. The company was founded in 2007 by Drs. Martin Woodle
and Puthupparampil Scaria to develop advanced biomedical nanoparticles for
in vivo research and tissue targeted therapeutics for treatment of cancer
and other diseases. AparnaBio has established a proprietary technology
platform, NanoElectroPlexTM, clinically viable nanoparticles for tissue
targeted delivery for RNAi, gene therapy, and other agents with
pharmacological properties that limit their therapeutic application.
AparnaBio has attracted support from federal, state, and local governmental
agents, including grants from NCI, NIAID, State of Maryland TEDCO and DBED,
and Montgomery County.